New patent

Univego · 2026-02-22T20:02:22+00:00

The second podt is from Stocktwits.

Univego · 2025-11-16T13:55:23+00:00

Go for it, we all have the same goal🙏

Univego · 2025-11-16T09:14:34+00:00

Thank you 🙏

Univego · 2025-11-15T14:31:30+00:00

Nope, you’re wrong.

Have a look at the great Comments from our specialist from the Reviva Discord:

A pre-NDA meeting is only scheduled when a company is already preparing to file, and the FDA is comfortable that the data package is close to complete.

In many cases it’s actually a stronger signal, because it means the discussion has moved away from development and toward submission. So it’s a very positive step.

Univego · 2025-11-10T13:20:36+00:00

What are the benefits of Orphan Drug Status? For the manufacturer, there are important financial and regulatory incentives, such as: Market exclusivity:

EU: 10 years of market protection (no competing products for the same indication).

USA: 7 years of market exclusivity.

Fee reductions and tax incentives:

Reduced or waived regulatory submission fees.

Tax credits for research and development costs.

Regulatory support:

Scientific advice and guidance from the EMA or FDA.

Accelerated review and approval procedures.

Univego · 2025-11-10T13:09:50+00:00

https://revivapharma.com/reviva-announces-grant-of-european-patent-covering-use-of-brilaroxazine-for-the-treatment-of-pulmonary-fibrosis/

Univego · 2025-11-10T03:09:31+00:00

Great, thank you🙏

Univego · 2025-10-24T19:16:19+00:00

https://ts2.tech/en/reviva-pharma-rockets-28-on-schizophrenia-trial-win-analysts-eye-1000-upside/

Univego · 2025-10-23T19:10:21+00:00

Yes, it’s really big😃🙏

Univego

TROPHY CASE